Nektar Therapeutics opposition analysis

COMPANY ANALYSIS

Latest patents of Nektar Therapeutics opposed by its competitors

Patent:
Grant Date:
Feb 17, 2021
Title:
Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody
Oppositions:
2
Patent:
Grant Date:
Mar 14, 2018
Title:
Negatively Biased Sealed Nebulizers Systems And Methods
Oppositions:
1
Patent:
Grant Date:
Dec 27, 2017
Title:
Combination-Based Treatment Method
Oppositions:
1

Want to track Nektar Therapeutics?

Feel free to send us a message here and we will get back to you